However, this study also indicates that simply inhibiting placental inflammasome activity to prevent preeclampsia-associated hypertension does not protect against placental insufficiency and inhibiting IL11 action is also required to improve fetal outcomes. The gene discussed is IL11; the disease is placental insufficiency.